» Articles » PMID: 1931602

Photocytotoxic Efficacy of Sulphonated Species of Aluminium Phthalocyanine Against Cell Monolayers, Multicellular Spheroids and in Vivo Tumours

Overview
Journal Br J Cancer
Specialty Oncology
Date 1991 Nov 1
PMID 1931602
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The problem of relying solely on in vitro data to predict photosensitiser efficacy was demonstrated by examining the uptake and the ability to mediate photocytotoxicity of mono-, di-, tri- and tetra-sulphonated species of chloroaluminium phthalocyanine (AlS1-4Pc) in monolayer cultures of murine Colo 26 cells and in both monolayer and spheroid cultures of human WiDr cells. Cells treated in vitro, whether in monolayer or as spheroids, with the less sulphonated derivatives, AlS1Pc and AlS2Pc, were more susceptible to photocytotoxicity than those treated with AlS3Pc, cells treated with AlS4Pc were even less susceptibile to the cytotoxic effects of light irradiation. Generally these results mirrored the cellular uptake in vitro. When WiDr spheroids were increased in size from 250 microns to 500 microns there was a reduction in uptake of AlS1Pc and AlS2Pc which was reflected by the decreased sensitivity of the larger spheroids to the effects of light irradiation. AlS1Pc had no effect against Colo 26 cells growing as s.c. tumours in syngeneic BALB/c mice; whereas AlS3Pc, AlS2Pc and AlS4Pc produced significant reductions in tumour weights 5 days post laser light irradiation. Of these, AlS2Pc had the most dramatic effect on the colony forming efficiency of tumour cells recovered 24 h after PDT. While, despite their effects on tumour size, AlS3Pc and AlS4Pc scarcely affected the subsequent viability of cells from dissociated tumours. Thus the in vitro efficacy of the sulphonated species of phthalocyanines is not necessarily predictive of their in vivo effectiveness.

Citing Articles

Phthalocyanine aggregates in the photodynamic therapy: dogmas, controversies, and future prospects.

Bunin D, Martynov A, Gvozdev D, Gorbunova Y Biophys Rev. 2023; 15(5):983-998.

PMID: 37975002 PMC: 10643719. DOI: 10.1007/s12551-023-01129-7.


Imaging of singlet oxygen feedback delayed fluorescence and lysosome permeabilization in tumor in vivo during photodynamic therapy with aluminum phthalocyanine.

Scholz M, Gunn J, Luke G, Pogue B J Biomed Opt. 2020; 25(6):1-14.

PMID: 31920049 PMC: 6951482. DOI: 10.1117/1.JBO.25.6.063806.


Design features for optimization of tetrapyrrole macrocycles as antimicrobial and anticancer photosensitizers.

Martinez de Pinillos Bayona A, Mroz P, Thunshelle C, Hamblin M Chem Biol Drug Des. 2017; 89(2):192-206.

PMID: 28205400 PMC: 5319686. DOI: 10.1111/cbdd.12792.


Like a bolt from the blue: phthalocyanines in biomedical optics.

Sekkat N, van den Bergh H, Nyokong T, Lange N Molecules. 2011; 17(1):98-144.

PMID: 22198535 PMC: 6269082. DOI: 10.3390/molecules17010098.


Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line.

Gupta S, Dwarakanath B, Muralidhar K, Koru-Sengul T, Jain V J Transl Med. 2010; 8:43.

PMID: 20433757 PMC: 2885318. DOI: 10.1186/1479-5876-8-43.


References
1.
Brasseur N, Ali H, Autenrieth D, Langlois R, van Lier J . Biological activities of phthalocyanines--III. Photoinactivation of V-79 Chinese hamster cells by tetrasulfophthalocyanines. Photochem Photobiol. 1985; 42(5):515-21. DOI: 10.1111/j.1751-1097.1985.tb01603.x. View

2.
Peng Q, Moan J, Nesland J, Rimington C . Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts. Int J Cancer. 1990; 46(4):719-26. DOI: 10.1002/ijc.2910460428. View

3.
Ben-Hur E, Rosenthal I . Photosensitization of Chinese hamster cells by water-soluble phthalocyanines. Photochem Photobiol. 1986; 43(6):615-9. DOI: 10.1111/j.1751-1097.1986.tb05636.x. View

4.
Spikes J . Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol. 1986; 43(6):691-9. DOI: 10.1111/j.1751-1097.1986.tb05648.x. View

5.
Tralau C, MacRobert A, Barr H, Bown S . Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. Br J Cancer. 1987; 55(4):389-95. PMC: 2001712. DOI: 10.1038/bjc.1987.78. View